Jan Doležel

800 total citations
48 papers, 628 citations indexed

About

Jan Doležel is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Jan Doležel has authored 48 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 13 papers in Surgery and 10 papers in Molecular Biology. Recurrent topics in Jan Doležel's work include Bladder and Urothelial Cancer Treatments (8 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Jan Doležel is often cited by papers focused on Bladder and Urothelial Cancer Treatments (8 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Jan Doležel collaborates with scholars based in Czechia, Germany and Austria. Jan Doležel's co-authors include Ondřej Slabý, Michal Staník, Marek Svoboda, Dalibor Pacík, Michal Fedorko, Robert Iliev, Alexandr Poprach, Táňa Macháčková, Jaroslav Juráček and Hana Mlčochová and has published in prestigious journals such as Cancer Research, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Jan Doležel

37 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Doležel Czechia 13 418 350 161 95 66 48 628
Michal Staník Czechia 12 486 1.2× 396 1.1× 152 0.9× 94 1.0× 66 1.0× 41 648
Rui Zhu China 11 328 0.8× 124 0.4× 104 0.6× 84 0.9× 23 0.3× 44 527
Dolores Byrne United States 7 487 1.2× 440 1.3× 54 0.3× 63 0.7× 8 0.1× 9 613
Jingxin Ding China 16 686 1.6× 597 1.7× 25 0.2× 49 0.5× 22 0.3× 41 925
Kazuki Heishima Japan 13 287 0.7× 222 0.6× 116 0.7× 31 0.3× 10 0.2× 36 453
Debora Landi Italy 13 698 1.7× 581 1.7× 49 0.3× 41 0.4× 14 0.2× 17 924
Yingjun Xie China 11 423 1.0× 366 1.0× 76 0.5× 44 0.5× 31 0.5× 20 623
Ola Elazazy Egypt 11 272 0.7× 292 0.8× 20 0.1× 48 0.5× 14 0.2× 18 416
Yuan Pan China 16 216 0.5× 96 0.3× 219 1.4× 132 1.4× 95 1.4× 48 580

Countries citing papers authored by Jan Doležel

Since Specialization
Citations

This map shows the geographic impact of Jan Doležel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Doležel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Doležel more than expected).

Fields of papers citing papers by Jan Doležel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Doležel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Doležel. The network helps show where Jan Doležel may publish in the future.

Co-authorship network of co-authors of Jan Doležel

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Doležel. A scholar is included among the top collaborators of Jan Doležel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Doležel. Jan Doležel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Staník, Michal, et al.. (2021). Oncological outcomes of surgery for isolated retroperitoneal recurrence in renal cancer patients after radical nephrectomy. Urologic Oncology Seminars and Original Investigations. 40(3). 111.e27–111.e34.
2.
Staník, Michal, et al.. (2019). Comparison of Different Treatment Modalities Outcomes in Clinically Node-positive Bladder Cancer: Analysis of a Population-based Cancer Registry. Clinical Genitourinary Cancer. 17(4). e759–e767. 8 indexed citations
3.
Staník, Michal, et al.. (2018). Sentinel lymph node dissection in prostate cancer using superparamagnetic particles of iron oxide: early clinical experience. International Urology and Nephrology. 50(8). 1427–1433. 4 indexed citations
5.
Staník, Michal, et al.. (2016). Neoadjuvantní chemoterapie u invazivních uroteliálních nádorů měchýře: korelace léčebné odpovědi a přežití pacientů. 20(3). 221–228.
6.
Slabý, Ondřej, Robert Iliev, Michal Staník, et al.. (2016). Decreased expression levels of PIWIL1, PIWIL2, and PIWIL4 are associated with worse survival in renal cell carcinoma patients. OncoTargets and Therapy. 9. 217–217. 45 indexed citations
7.
Iliev, Robert, Michal Fedorko, Táňa Macháčková, et al.. (2016). Expression Levels of PIWI-interacting RNA, piR-823, Are Deregulated in Tumor Tissue, Blood Serum and Urine of Patients with Renal Cell Carcinoma. Anticancer Research. 36(12). 6419–6424. 79 indexed citations
8.
Staník, Michal, et al.. (2015). Krátkodobé onkologické výsledky po radikální prostatektomii s rozšířenou pánevní lymfadenektomií a s nálezem uzlinových metastáz. Lze pomýšlet na úspěch bez systémové léčby. 19(2). 137–144.
9.
Staník, Michal, et al.. (2014). Sentinel lymph node dissection combined with meticulous histology increases the detection rate of nodal metastases in prostate cancer. International Urology and Nephrology. 46(8). 1543–1549. 18 indexed citations
10.
Doležel, Jan, et al.. (2013). Systematic Mediastinal Lymphadenectomy in Surgery for Sarcomatous Pulmonary Metastases. Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca. 80(1). 77–81.
11.
Staník, Michal, et al.. (2013). Vyšetření sentinelové uzliny u karcinomu prostaty - mapování primární lymfatické drenáže a zhodnocení přínosu pro staging onemocnění. 17(1). 42–50. 2 indexed citations
12.
Staník, Michal, et al.. (2012). Krvácení do skrota jako první příznak metastazování karcinomu prostaty do nadvarlete. 16(2). 121–124.
13.
Staník, Michal, et al.. (2012). Primary adenocarcinoma of the epididymis: the therapeutic role of retroperitoneal lymphadenectomy. International Urology and Nephrology. 44(4). 1049–1053. 7 indexed citations
14.
Křen, Leoš, Jan Doležel, Dalibor Pacík, et al.. (2012). HLA-G and HLA-E specific mRNAs connote opposite prognostic significance in renal cell carcinoma. Diagnostic Pathology. 7(1). 58–58. 28 indexed citations
15.
Doležel, Jan, et al.. (2009). Časné zkušenosti s roboticky asistovanou laparo skopickou radikální prostatektomií - prvních 153 pacientů. 13(2). 168–177.
16.
Doležel, Jan, et al.. (2009). Mediastinální lymfadenektomie v chirurgii plicních metastáz. 88(5).
17.
Doležel, Jan, et al.. (2009). Our early experience with robotic-assisted laparoscopic radical prostatectomy - first 153 cases. 13(2). 168–177. 1 indexed citations
18.
Doležel, Jan, et al.. (2007). Metastazektomie vícečetných plicních metastáz nízce diferencovaného synoviálního sarkomu. 86(2). 1 indexed citations
19.
Doležel, Jan, et al.. (2004). Antireflux Uretero-Intestinal Anastomosis—Flap-and-Trough Technique—Applicable to Ileum: Early Clinical Experience. European Urology. 46(5). 598–603. 1 indexed citations
20.
Beneš, Jiří, et al.. (2000). Abdominoinguinal Pain Syndrome Treated by Centrocentral Anastomosis. Acta Neurochirurgica. 142(8). 887–891. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026